Archives

Psilocybin helps reduce depression in clinicians amid COVID-19 crisis

Psilocybin-assisted psychotherapy resulted in significant reductions in depression among clinicians who provided front-line COVID-19 care in 2020 and 2021. These reductions were measurably greater than those experienced by the…
Read More...

Psilocybin therapy reduces depression in clinicians after pandemic frontline work

A randomized trial shows significant improvements in depression symptoms among healthcare workers using psilocybin, highlighting a potential breakthrough in mental health care. Study: Psilocybin Therapy for Clinicians With…
Read More...

Study highlights the potential of psilocybin in treating obsessive-compulsive disorder

A new study highlights the potential of psilocybin, a psychedelic compound, in treating obsessive-compulsive disorder (OCD) and Tourette's Syndrome. Research conducted on mice showed that psilocybin and psychedelic mushroom…
Read More...